205 related articles for article (PubMed ID: 10845833)
1. Protection of alpha(3) integrin-mediated podocyte shape by superoxide dismutase in the puromycin aminonucleoside nephrosis rat.
Kojima K; Matsui K; Nagase M
Am J Kidney Dis; 2000 Jun; 35(6):1175-85. PubMed ID: 10845833
[TBL] [Abstract][Full Text] [Related]
2. Dipyridamole and dilazep suppress oxygen radicals in puromycin aminonucleoside nephrosis rats.
Nakamura K; Kojima K; Arai T; Shirai M; Usutani S; Akimoto H; Masaoka H; Nagase M; Yamamoto M
Eur J Clin Invest; 1998 Nov; 28(11):877-83. PubMed ID: 9824428
[TBL] [Abstract][Full Text] [Related]
3. [Effects of human Cu, Zn-superoxide dismutase in aminonucleoside nephrosis--evaluation of the morphology and glomerular basement membrane anionic charge sites].
Higuchi A
Nihon Jinzo Gakkai Shi; 1990 Jul; 32(7):767-75. PubMed ID: 2273594
[TBL] [Abstract][Full Text] [Related]
4. Tolvaptan, a selective oral vasopressin V2 receptor antagonist, ameliorates podocyte injury in puromycin aminonucleoside nephrotic rats.
Okada T; Sakaguchi T; Hatamura I; Saji F; Negi S; Otani H; Muragaki Y; Kawachi H; Shigematsu T
Clin Exp Nephrol; 2009 Oct; 13(5):438-446. PubMed ID: 19452240
[TBL] [Abstract][Full Text] [Related]
5. Impact of cyclosporin on podocyte ZO-1 expression in puromycin aminonucleoside nephrosis rats.
Kim BS; Park HC; Kang SW; Choi KH; Ha SK; Han DS; Lee HY
Yonsei Med J; 2005 Feb; 46(1):141-8. PubMed ID: 15744817
[TBL] [Abstract][Full Text] [Related]
6. Dynamics of absolute amount of nephrin in a single podocyte in puromycin aminonucleoside nephrosis rats calculated by quantitative glomerular proteomics approach with selected reaction monitoring mode.
Kawakami H; Kamiie J; Yasuno K; Kobayashi R; Aihara N; Shirota K
Nephrol Dial Transplant; 2012 Apr; 27(4):1324-30. PubMed ID: 21862459
[TBL] [Abstract][Full Text] [Related]
7. Amelioration of antioxidant enzyme suppression and proteinuria in cyclosporin-treated puromycin nephrosis.
Wang JS; Yang AH; Chen SM; Young TK; Chiang H; Liu HC
Nephron; 1993; 65(3):418-25. PubMed ID: 8289993
[TBL] [Abstract][Full Text] [Related]
8. Retinoids as a potential treatment for experimental puromycin-induced nephrosis.
Moreno-Manzano V; Mampaso F; Sepúlveda-Muñoz JC; Alique M; Chen S; Ziyadeh FN; Iglesias-de la Cruz MC; Rodríguez J; Nieto E; Orellana JM; Reyes P; Arribas I; Xu Q; Kitamura M; Lucio Cazana FJ
Br J Pharmacol; 2003 Jun; 139(4):823-31. PubMed ID: 12813006
[TBL] [Abstract][Full Text] [Related]
9. Antioxidants protect podocyte foot processes in puromycin aminonucleoside-treated rats.
Ricardo SD; Bertram JF; Ryan GB
J Am Soc Nephrol; 1994 Jun; 4(12):1974-86. PubMed ID: 7919151
[TBL] [Abstract][Full Text] [Related]
10. GLEPP1 receptor tyrosine phosphatase (Ptpro) in rat PAN nephrosis. A marker of acute podocyte injury.
Kim YH; Goyal M; Wharram B; Wiggins J; Kershaw D; Wiggins R
Nephron; 2002 Apr; 90(4):471-6. PubMed ID: 11961407
[TBL] [Abstract][Full Text] [Related]
11. Puromycin aminonucleoside suppresses integrin expression in cultured glomerular epithelial cells.
Krishnamurti U; Zhou B; Fan WW; Tsilibary E; Wayner E; Kim Y; Kashtan CE; Michael A
J Am Soc Nephrol; 2001 Apr; 12(4):758-766. PubMed ID: 11274237
[TBL] [Abstract][Full Text] [Related]
12. Protective effect of radical scavenger edaravone against puromycin nephrosis.
Matsumura H; Ashida A; Hirano K; Nakakura H; Tamai H
Clin Nephrol; 2006 Dec; 66(6):405-10. PubMed ID: 17176911
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of puromycin-induced renal injury by a superoxide dismutase derivative with prolonged in vivo half-life.
Nishimura Y; Nakayama M; Sato T; Tomita K; Inoue M
Nephron; 1995; 70(4):460-5. PubMed ID: 7477653
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of heparin-binding epidermal growth factor-like growth factor increases albuminuria in puromycin aminonucleoside nephrosis.
Khong TF; Fraser S; Katerelos M; Paizis K; Hill PA; Power DA
Kidney Int; 2000 Sep; 58(3):1098-107. PubMed ID: 10972674
[TBL] [Abstract][Full Text] [Related]
15. Studies on antinephritic effect of TJ-8014, syo-saiko-to-kyo-shyokyo-ka-ouren-bukuryou (5): Effects on puromycin aminonucleoside nephrosis and its mechanisms.
Hattori T; Ito M; Suzuki Y
Jpn J Pharmacol; 1991 Aug; 56(4):465-73. PubMed ID: 1744988
[TBL] [Abstract][Full Text] [Related]
16. Reduced podocyte expression of alpha3beta1 integrins and podocyte depletion in patients with primary focal segmental glomerulosclerosis and chronic PAN-treated rats.
Chen CA; Hwang JC; Guh JY; Chang JM; Lai YH; Chen HC
J Lab Clin Med; 2006 Feb; 147(2):74-82. PubMed ID: 16459165
[TBL] [Abstract][Full Text] [Related]
17. Glucocorticoid activates glomerular antioxidant enzymes and protects glomeruli from oxidant injuries.
Kawamura T; Yoshioka T; Bills T; Fogo A; Ichikawa I
Kidney Int; 1991 Aug; 40(2):291-301. PubMed ID: 1942778
[TBL] [Abstract][Full Text] [Related]
18. Altered expression of NDST-1 messenger RNA in puromycin aminonucleoside nephrosis.
Nakayama K; Natori Y; Sato T; Kimura T; Sugiura A; Sato H; Saito T; Ito S; Natori Y
J Lab Clin Med; 2004 Feb; 143(2):106-14. PubMed ID: 14966466
[TBL] [Abstract][Full Text] [Related]
19. Reactive oxygen species and antioxidant defense in puromycin aminonucleoside glomerulopathy.
Gwinner W; Landmesser U; Brandes RP; Kubat B; Plasger J; Eberhard O; Koch KM; Olbricht CJ
J Am Soc Nephrol; 1997 Nov; 8(11):1722-31. PubMed ID: 9355075
[TBL] [Abstract][Full Text] [Related]
20. Key molecular events in puromycin aminonucleoside nephrosis rats.
Guan N; Ding J; Deng J; Zhang J; Yang J
Pathol Int; 2004 Sep; 54(9):703-11. PubMed ID: 15363039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
